Need professional-grade analysis? Visit stockanalysis.com
$3.00B
53.50
629
1.64%
Chemclin Diagnostics Co. Ltd. A (688468) trades on SHG in CNY. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at CNY7.27, up 0.69% from the previous close.
Over the past year, 688468 has traded between a low of CNY6.74 and a high of CNY8.94. The stock has gained 4.9% over this period. It is currently 18.7% below its 52-week high.
Chemclin Diagnostics Co. Ltd. A has a market capitalization of $3.00B, with a price-to-earnings ratio of 53.50 and a dividend yield of 1.64%.
Chemclin Diagnostics Co., Ltd. engages in the research and development, production, and sale of clinical immune chemiluminescence diagnostic reagents and instruments. Its products include LiCAA series of diagnostic reagents based on photo-induced chemiluminescence and CC series based on enzymatic chemiluminescence diagnostic reagents and instruments, primarily used for infectious diseases, such as hepatitis B, hepatitis C, AIDS, syphilis, hepatitis A, hepatitis E, etc.; and detection of tumor markers, thyroid hormones, reproductive endocrine hormones, cardiac markers, and inflammation. The company was founded in 2007 and is headquartered in Beijing, China.
Side-by-side comparison against top Healthcare peers.